Clinical Trial Update: Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A multicenter clinical trial evaluating the ST-02 therapy for ablation of upper tract urothelial carcinoma (renal pelvis and ureter) is currently recruiting for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Drugs mentioned

• ST-02

Snippet

Sponsor: University of British Columbia | Conditions: Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2, Phase 3 | Status: RECRUITING